Recognizing the Importance of Critical Minerals in Healthcare Act of 2023

H.R. 6395, now Public Law 118-233, was signed by the President on January 4, 2025, during the 118th Congress. The law amends the Energy Act of 2020 to insert 'Health and Human Services' alongside 'Agriculture' in two statutory provisions governing critical mineral designations. This ensures that the Department of Health and Human Services (HHS) is consulted when the Secretary of the Interior evaluates whether a mineral, element, substance, or material qualifies as 'critical' under federal law. The bill passed the House on December 3, 2024, and the Senate on December 20, 2024, with bipartisan support (3 cosponsors from both parties). The legislation is strictly procedural: it adds a consultation requirement but authorizes no new spending, creates no new programs, and imposes no direct regulatory burden on companies. The impact on healthcare or materials markets is negligible because the designation process itself is already mature and this change simply adds a stakeholder review. There is no funding stream, no tax credit, and no procurement mandate. Retail investors should see this as a non-event for public companies. The law has no measurable revenue impact on any publicly traded entity. The only implication is that future critical mineral designations will formally include healthcare supply chain considerations, but this does not change existing supply or demand dynamics for medical device raw materials, pharmaceutical ingredients, or battery minerals.